In the News

Dr. Andreana Holowatyj's research on appendiceal cancer was featured in stories in the New York Post and the UK's Daily Mail. Click the links below to read the articles. https://nypost.com/2024/01/09/lifestyle/what-is-appendiceal-cancer-actor-adan-canto-dead-from-rare-disease/  

Andreana Holowatyj, PhD, MSCI, assistant professor of Medicine, has received the National Cancer Institute’s Method to Extend Research in Time (MERIT) Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health.

The Genetics of Appendix Cancer (GAP) Study is a research study of individuals with an appendix cancer diagnosis and their families. The goal of the GAP Study is to answer the question of: Is there a genetic link to appendix cancer? The GAP Study is a national crowdsourcing study of individuals who received an appendix cancer diagnosis between the ages of 18 and 99 years old.

A first look into where early onset mortality spikes among U.S. women. Women with early onset colorectal cancer have a greater risk of dying from the disease depending upon their county of residence, according to a study published in Clinical and Translational Gastroenterology.

Appendiceal cancer — cancer of the appendix — is a rare malignancy that is usually found during surgery for acute appendicitis. Although the rate of appendectomies has been stable over the last two decades, the incidence of malignant appendiceal cancer increased 232% in the United States.